Member Info for MoreThanMe

200-300p base case, increasing if we expand further than the 2m/week that we are currently on track for. Other factors that could increase our value more is if the perceived duration of the pandemic increases, which I truly hope is not the case.

£0.7605 to sell quantity

£0.752 to sell

74p to sell 30k+ shares

"The demand for rapid testing continues to grow.

Reliable manufacturing solutions are required to support fast, accurate and easy-to-use testing to combat #COVID19

Learn how the AbC-19 antibody test will play an invaluable role in rapid testing: https://abc19.com/white-paper/

#ODX"

For those that don't do Twitter.

Another Tweet from Omega
https://twitter.com/OmegaDiagnostic/status/1309086886309310469

In the Brr Media presentation today at 4:10-4:25 Collin corrects himself when mentioning the volumes of covid testing:
"Clearly the volumes that we require to manufacture are large... or potentially large"

There are definitely orders in place that the company is not able to yet inform the market of.

72.59p is the prior highest close on the 1st of June, that was broken the other week, we are now testing this support level, where we will bounce. Great buying oppertunity IMO. This is a cerca 50% retracement from the recent move from 53p to 95p. Looks like some healthy consolidation that will help in future legs up. See graph linked below:

https://imgur.com/a/zGXA7V6

Can sell entire holding above the current market price at 80.25p, this is headed up.

The DNA nudge box can only hold one sample at a time and each sample takes 90 minutes to get a result, giving a theoretical max output of 16 results/day if used 24 hours a day. 94.4% sensitivity so it will miss 5.6 cases in 100.

I really hope the governement did not spend a lot of money on this, i didnt think tests with such low accuraccy were even allowed to be rolled out. It just makes a stronger case for Mologics antigen LFT.

Completely agree, ODX is only going to become more important and more valuable as a company as we get further into autumn and winter. People will wake up to the importance of testing and especially LFTs that give an instant result wherever you are, especially as colds/flu becomes more prevalent. Demand for tests will sky rocket even more than it is currently and by that time our capacity will be a lot higher and the company will be thinking about expansion above 2m tests / week.

I am guessing people selling some now are either sitting on huge profits that they want to bank, haven't researched the company or can't fathom the scale of demand for LFT, when the public are made aware of them.

It is natural for people to take profits and before the 52 week high would be a target set by many people to bank some profits. Without news, I think we will churn at 85-90 for today and tomorrow, but when we run out of profit takers or get news, this will run up fast straight through £1 and not look back.

Also Boris on Skynews youtube
https://www.youtube.com/watch?v=9Auq9mYxFEE

@shareinthis
https://twitter.com/Sjopinion10/status/1304078417508347905

Very interesting article in the FT today about iAbra, it's false claims, lack of industry experience, tiny size of company and connections to non-reputable companies. Intel have taken down mentions of their connection to company from their website. Here is just one quote from the article:

"The credentials of the technology are further muddied by apparent connections to an organisation that spent decades working on hoaxes about the fictional monster Big Foot."

Did this company not get vetted by Heathrow at all?

https://www.ft.com/content/e7a279df-3239-4e00-be29-f38d98f4d730

With iAbra revealing that their machine is only at a proof of concept stage, Mologics antigen LFT is looking even more attractive. TT electronics are down 10% today and 19% from when their RNS was released, so iAbra's machine was not all it was made out to be.

If you aren't used to tree shakes by now, you obviously haven't held here for long. Many months of open 4% down to finish 1% up.

We might need to get Collin a tie at this rate. GLA

Like a £250k trade?

No# 6 in HL most viewed shares today and No# 7 in the most traded shares in the last week. There is a lot of new interest here, I just don't understand why people couldn't see the potential when we were stuck in the 50p range. But the market isn't always as efficient as people say.